0001752724-23-220923.txt : 20230928 0001752724-23-220923.hdr.sgml : 20230928 20230928095049 ACCESSION NUMBER: 0001752724-23-220923 CONFORMED SUBMISSION TYPE: NPORT-P PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20230731 FILED AS OF DATE: 20230928 DATE AS OF CHANGE: 20230928 PERIOD START: 20231031 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ALGER INSTITUTIONAL FUNDS CENTRAL INDEX KEY: 0000911415 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1031 FILING VALUES: FORM TYPE: NPORT-P SEC ACT: 1940 Act SEC FILE NUMBER: 811-07986 FILM NUMBER: 231286777 BUSINESS ADDRESS: STREET 1: 100 PEARL STREET STREET 2: 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 212-806-8800 MAIL ADDRESS: STREET 1: 100 PEARL STREET STREET 2: 27TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10004 FORMER COMPANY: FORMER CONFORMED NAME: ALGER INSTITUTIONAL FUND DATE OF NAME CHANGE: 20020228 FORMER COMPANY: FORMER CONFORMED NAME: ALGER RETIREMENT FUND DATE OF NAME CHANGE: 19960515 FORMER COMPANY: FORMER CONFORMED NAME: ALGER DEFINED CONTRIBUTION TRUST DATE OF NAME CHANGE: 19930830 0000911415 S000009202 Alger Small Cap Growth Institutional Fund C000025000 Alger Small Cap Growth Institutional Fund Class I ALSRX C000025001 Alger Small Cap Growth Institutional Fund Class R ASIRX C000172687 Alger Small Cap Growth Institutional Fund Class Z-2 AISZX NPORT-P 1 primary_doc.xml NPORT-P false 0000911415 XXXXXXXX S000009202 C000025000 C000172687 C000025001 ALGER INSTITUTIONAL FUNDS 811-07986 0000911415 549300YADKM68VK1G468 100 Pearl Street NULL New York 10004 212-806-8833 Alger Small Cap Growth Institutional Fund S000009202 549300H22X5UMMSPFQ06 2023-10-31 2023-07-31 N 140289554.76 636624.69 139652930.07 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 0.00000000 312209.13000000 N MAGNITE INC 54930018FR2YX1HHSB02 MAGNITE INC 0.00000000 55955D100 58652.00000000 NS USD 887404.76000000 0.635435833358 Long EC CORP US N 1 N N N CROSSLINK VENTURES C LLC N/A CROSSLINK VENTURES C LLC CALSS A SHARES 0.00000000 N/A 51.00000000 NS USD 1328193.00000000 0.951067048385 Long EC CORP US Y 3 N N N BUMBLE INC-A N/A BUMBLE INC-A 0.00000000 12047B105 28543.00000000 NS USD 528616.36000000 0.378521495922 Long EC CORP US N 1 N N N KURA SUSHI USA INC-CLASS A N/A KURA SUSHI USA INC-CLASS A 0.00000000 501270102 21124.00000000 NS USD 2102049.24000000 1.505195228590 Long EC CORP US N 1 N N N CELLDEX THERAPEUTICS INC 529900F018DMYWH38923 CELLDEX THERAPEUTICS INC 0.00000000 15117B202 21328.00000000 NS USD 754158.08000000 0.540023098421 Long EC CORP US N 1 N N N IMPULSE DYNAMICS IRELAND N/A IMPULSE DYNAMICS IRELAND 0.00000000 N/A 532406.00000000 NS USD 1756939.80000000 1.258075859288 Long EC CORP IE Y 3 N N N Q2 HOLDINGS INC 549300M9RKR9DZXWS696 Q2 HOLDINGS INC 0.00000000 74736L109 48569.00000000 NS USD 1722742.43000000 1.233588460432 Long EC CORP US N 1 N N N DOXIMITY INC-CLASS A N/A DOXIMITY INC-CLASS A 0.00000000 26622P107 7724.00000000 NS USD 275978.52000000 0.197617421891 Long EC CORP US N 1 N N N SOLAREDGE TECHNOLOGIES INC 5493000K6Y58XXPDF853 SOLAREDGE TECHNOLOGIES INC 0.00000000 83417M104 4446.00000000 NS USD 1073531.16000000 0.768713667133 Long EC CORP IL N 1 N N N REATA PHARMACEUTICALS INC-A 5299005F094GH9QDDD80 REATA PHARMACEUTICALS INC-A 0.00000000 75615P103 6984.00000000 NS USD 1156410.72000000 0.828060477800 Long EC CORP US N 1 N N N AVIDITY BIOSCIENCES INC N/A AVIDITY BIOSCIENCES INC 0.00000000 05370A108 29546.00000000 NS USD 280982.46000000 0.201200547571 Long EC CORP US N 1 N N N MAGNOLIA OIL & GAS CORP - A N/A MAGNOLIA OIL & GAS CORP - A 0.00000000 559663109 162878.00000000 NS USD 3607747.70000000 2.583366992866 Long EC CORP US N 1 N N N CHEESECAKE FACTORY INC/THE 529900872XMLK10SY247 CHEESECAKE FACTORY INC/THE 0.00000000 163072101 33851.00000000 NS USD 1245039.78000000 0.891524280497 Long EC CORP US N 1 N N N MERCURY SYSTEMS INC 549300P3B84SGK7HH679 MERCURY SYSTEMS INC 0.00000000 589378108 38152.00000000 NS USD 1449012.96000000 1.037581495263 Long EC CORP US N 1 N N N CAPRI HOLDINGS LTD 549300LPG8W0H1OX3A26 CAPRI HOLDINGS LTD 0.00000000 G1890L107 41136.00000000 NS USD 1518329.76000000 1.087216544070 Long EC CORP GB N 1 N N N VENTYX BIOSCIENCES INC N/A VENTYX BIOSCIENCES INC 0.00000000 92332V107 10465.00000000 NS USD 387728.25000000 0.277637031894 Long EC CORP US N 1 N N N HEALTHEQUITY INC 529900LRJU1RAFQHM467 HEALTHEQUITY INC 0.00000000 42226A107 37533.00000000 NS USD 2549992.02000000 1.825949529824 Long EC CORP US N 1 N N N HEICO CORP 529900O1DTDLCJ7L0I14 HEICO CORP 0.00000000 422806109 22096.00000000 NS USD 3888454.08000000 2.784369850350 Long EC CORP US N 1 N N N SPROUT SOCIAL INC - CLASS A N/A SPROUT SOCIAL INC - CLASS A 0.00000000 85209W109 30878.00000000 NS USD 1764368.92000000 1.263395561493 Long EC CORP US N 1 N N N RAPT THERAPEUTICS INC 549300MB473BIU78ES48 RAPT THERAPEUTICS INC 0.00000000 75382E109 30555.00000000 NS USD 730264.50000000 0.522913840500 Long EC CORP US N 1 N N N PROPETRO HOLDING CORP N/A PROPETRO HOLDING CORP 0.00000000 74347M108 67383.00000000 NS USD 703478.52000000 0.503733448089 Long EC CORP US N 1 N N N BALCHEM CORP 549300VR70OPMHUI3557 BALCHEM CORP 0.00000000 057665200 11268.00000000 NS USD 1518250.32000000 1.087159660194 Long EC CORP US N 1 N N N PROSETTA BIOSCIENCES INC. /PFD N/A PROSETTA BIOSCIENCES INC. SERIES D PREFERRED 0.00000000 N/A 133263.00000000 NS USD 0.00000000 0.000000 Long EP CORP US Y 3 N N N ARITZIA INC-SUBORDINATE /CAD/ 549300U83HKFRL1EX527 ARITZIA INC-SUBORDINATE VOTI /CAD/ 0.00000000 04045U102 10957.00000000 NS 208447.61000000 0.149261179049 Long EC CORP CA N 1 N N N SUNRUN INC 54930007SJ77CI66U531 SUNRUN INC 0.00000000 86771W105 32054.00000000 NS USD 608384.92000000 0.435640641191 Long EC CORP US N 1 N N N SKYLINE CHAMPION CORP N/A SKYLINE CHAMPION CORP 0.00000000 830830105 9683.00000000 NS USD 674517.78000000 0.482995795120 Long EC CORP US N 1 N N N CABALETTA BIO INC N/A CABALETTA BIO INC 0.00000000 12674W109 114375.00000000 NS USD 1557787.50000000 1.115470688097 Long EC CORP US N 1 N N N MANHATTAN ASSOCIATES INC 529900Q1GJP7KD52SW51 MANHATTAN ASSOCIATES INC 0.00000000 562750109 27197.00000000 NS USD 5184292.14000000 3.712268791926 Long EC CORP US N 1 N N N MARQETA INC-A 254900UZARK0FMZGZE18 MARQETA INC-A 0.00000000 57142B104 115506.00000000 NS USD 644523.48000000 0.461518050267 Long EC CORP US N 1 N N N SHAKE SHACK INC - CLASS A 529900J74GJAHYP80N79 SHAKE SHACK INC - CLASS A 0.00000000 819047101 29210.00000000 NS USD 2268448.60000000 1.624347300742 Long EC CORP US N 1 N N N NANOSTRING TECHNOLOGIES INC 549300G4CK0Y3WRDMY89 NANOSTRING TECHNOLOGIES INC 0.00000000 63009R109 63851.00000000 NS USD 303930.76000000 0.217632927463 Long EC CORP US N 1 N N N HUBSPOT INC 529900BLNVEW0MVKJB37 HUBSPOT INC 0.00000000 443573100 6842.00000000 NS USD 3972123.10000000 2.844281962440 Long EC CORP US N 1 N N N MESA LABORATORIES INC 549300ZCG738WLX8ZW79 MESA LABORATORIES INC 0.00000000 59064R109 3769.00000000 NS USD 484919.54000000 0.347231912539 Long EC CORP US N 1 N N N PETIQ INC 549300GROACFGKVYOX14 PETIQ INC 0.00000000 71639T106 25789.00000000 NS USD 431707.86000000 0.309129110132 Long EC CORP US N 1 N N N CHAMPIONX CORP 549300EP2909K6DYYP38 CHAMPIONX CORP 0.00000000 15872M104 32871.00000000 NS USD 1170207.60000000 0.837939883834 Long EC CORP US N 1 N N N CHIME FINANCIAL INC /PFD/ N/A CHIME FINANCIAL INC F/K/A 1DEBIT INC SERIES G /PREFERRED/ RESTRICTED/ 0.00000000 N/A 114399.00000000 NS USD 4908861.09000000 3.515043391885 Long EP CORP US Y 3 N N N LIVE NATIONAL ENTERTAINMENT INC 5493007B9BM9ZXJINO78 LIVE NATIONAL ENTERTAINMENT INC 0.00000000 538034109 29285.00000000 NS USD 2569758.75000000 1.840103711903 Long EC CORP US N 1 N N N DLOCAL LTD N/A DLOCAL LTD 0.00000000 G29018101 70819.00000000 NS USD 1074324.23000000 0.769281553535 Long EC CORP UY N 1 N N N AKOYA BIOSCIENCES INC N/A AKOYA BIOSCIENCES INC 0.00000000 00974H104 60048.00000000 NS USD 414331.20000000 0.296686363681 Long EC CORP US N 1 N N N ACI WORLDWIDE INC 5493003BPVMZUJ6F5C02 ACI WORLDWIDE INC 0.00000000 004498101 62376.00000000 NS USD 1446499.44000000 1.035781661920 Long EC CORP US N 1 N N N ACELYRIN INC N/A ACELYRIN INC 0.00000000 00445A100 11317.00000000 NS USD 281114.28000000 0.201294938716 Long EC CORP US N 1 N N N PLIANT THERAPEUTICS INC 5493002Q5LITR7VHZH02 PLIANT THERAPEUTICS INC 0.00000000 729139105 22329.00000000 NS USD 398349.36000000 0.285242393267 Long EC CORP US N 1 N N N BLACKLINE INC 529900P9N7PK9LV5EK56 BLACKLINE INC 0.00000000 09239B109 29917.00000000 NS USD 1737579.36000000 1.244212605585 Long EC CORP US N 1 N N N CRYOPORT INC 9845004D8538BT8JF626 CRYOPORT INC 0.00000000 229050307 51379.00000000 NS USD 825660.53000000 0.591223205690 Long EC CORP US N 1 N N N XOMETRY INC-A 5493006JFRGU7YRRXE44 XOMETRY INC-A 0.00000000 98423F109 27198.00000000 NS USD 564630.48000000 0.404309798381 Long EC CORP US N 1 N N N INMODE LTD 984500DD95A35E9BD358 INMODE LTD 0.00000000 M5425M103 37353.00000000 NS USD 1602817.23000000 1.147714716187 Long EC CORP IL N 1 N N N ODDITY TECH LTD-CL A N/A ODDITY TECH LTD-CL A 0.00000000 M7518J104 13730.00000000 NS USD 731671.70000000 0.523921481370 Long EC CORP IL N 1 N N N MAXCYTE INC 54930053YHXULRFCU991 MAXCYTE INC 0.00000000 57777K106 80083.00000000 NS USD 357971.01000000 0.256329036433 Long EC CORP US N 1 N N N QUIDELORTHO CORP 549300YU8CMO9HF53113 QUIDELORTHO CORP 0.00000000 219798105 32314.00000000 NS USD 2822951.04000000 2.021404805889 Long EC CORP US N 1 N N N RAPID7 INC 549300GNVG5D60KEYN14 RAPID7 INC 0.00000000 753422104 11833.00000000 NS USD 543253.03000000 0.389002242722 Long EC CORP US N 1 N N N ARCUS BIOSCIENCES INC N/A ARCUS BIOSCIENCES INC 0.00000000 03969F109 17175.00000000 NS USD 341782.50000000 0.244737077717 Long EC CORP US N 1 N N N PLANET FITNESS INC - CL A 549300LLE5HUPF6H8G33 PLANET FITNESS INC - CL A 0.00000000 72703H101 21217.00000000 NS USD 1432996.18000000 1.026112505682 Long EC CORP US N 1 N N N TAKE-TWO INTERACTIVE SOFTWRE BOMSTHHJK882EWYX3334 TAKE-TWO INTERACTIVE SOFTWRE 0.00000000 874054109 14524.00000000 NS USD 2221300.56000000 1.590586433730 Long EC CORP US N 1 N N N TANDEM DIABETES CARE INC 549300JEPFOD0K4D3I05 TANDEM DIABETES CARE INC 0.00000000 875372203 30237.00000000 NS USD 1055876.04000000 0.756071526369 Long EC CORP US N 1 N N N BILL HOLDINGS INC 549300IBF9VZZIGOZW63 BILL HOLDINGS INC 0.00000000 090043100 19264.00000000 NS USD 2414549.76000000 1.728964625940 Long EC CORP US N 1 N N N TRIPADVISOR INC 549300XVG45PT5BART17 TRIPADVISOR INC 0.00000000 896945201 33825.00000000 NS USD 630836.25000000 0.451717160308 Long EC CORP US N 1 N N N WINGSTOP INC N/A WINGSTOP INC 0.00000000 974155103 19374.00000000 NS USD 3266068.92000000 2.338704184984 Long EC CORP US N 1 N N N CHEFS' WAREHOUSE INC/THE 549300JYEDC8C547E980 CHEFS' WAREHOUSE INC/THE 0.00000000 163086101 40013.00000000 NS USD 1454072.42000000 1.041204376643 Long EC CORP US N 1 N N N ADMA BIOLOGICS INC N/A ADMA BIOLOGICS INC 0.00000000 000899104 208870.00000000 NS USD 866810.50000000 0.620689089420 Long EC CORP US N 1 N N N RB GLOBAL INC 5493002H8U24DJXQ4886 RB GLOBAL INC 0.00000000 74935Q107 9766.00000000 NS USD 629711.68000000 0.450911899724 Long EC CORP CA N 1 N N N COTERRA ENERGY INC FCNMH6O7VWU7LHXMK351 COTERRA ENERGY INC 0.00000000 127097103 34770.00000000 NS USD 957565.80000000 0.685675409402 Long EC CORP US N 1 N N N ON HOLDING AG-CLASS A N/A ON HOLDING AG-CLASS A 0.00000000 H5919C104 22379.00000000 NS USD 805644.00000000 0.576890151603 Long EC CORP CH N 1 N N N BLACKBAUD INC 54930056X3HKFMNG3754 BLACKBAUD INC 0.00000000 09227Q100 21038.00000000 NS USD 1587317.10000000 1.136615679459 Long EC CORP US N 1 N N N HEXCEL CORP S6Q7LW43WUBUHXY2QP69 HEXCEL CORP 0.00000000 428291108 10920.00000000 NS USD 771825.60000000 0.552674118339 Long EC CORP US N 1 N N N GATES INDUSTRIAL CORP PLC N/A GATES INDUSTRIAL CORP PLC 0.00000000 G39108108 68151.00000000 NS USD 928216.62000000 0.664659609744 Long EC CORP US N 1 N N N PAYCOM SOFTWARE INC 254900LSB0HNJUDC6Q18 PAYCOM SOFTWARE INC 0.00000000 70432V102 2624.00000000 NS USD 967626.24000000 0.692879296922 Long EC CORP US N 1 N N N SHOCKWAVE MEDICAL INC 549300LDXO56IC5Y1538 SHOCKWAVE MEDICAL INC 0.00000000 82489T104 2483.00000000 NS USD 647069.80000000 0.463341370407 Long EC CORP US N 1 N N N AFFILIATED MANAGERS GROUP 2JE75BUE3T1BLCYYGK54 AFFILIATED MANAGERS GROUP 0.00000000 008252108 4469.00000000 NS USD 619582.16000000 0.443658546719 Long EC CORP US N 1 N N N MORPHIC HOLDING INC 549300RWWOUFLHTY1224 MORPHIC HOLDING INC 0.00000000 61775R105 14724.00000000 NS USD 835292.52000000 0.598120296925 Long EC CORP US N 1 N N N SMARTSHEET INC-CLASS A 549300N9WF42OK9VL589 SMARTSHEET INC-CLASS A 0.00000000 83200N103 31943.00000000 NS USD 1418269.20000000 1.015567091423 Long EC CORP US N 1 N N N US FOODS HOLDING CORP 549300UGOZSO64CFPR97 US FOODS HOLDING CORP 0.00000000 912008109 68800.00000000 NS USD 2939824.00000000 2.105092960474 Long EC CORP US N 1 N N N ALKERMES PLC N/A ALKERMES PLC 0.00000000 G01767105 16590.00000000 NS USD 485755.20000000 0.347830295974 Long EC CORP IE N 1 N N N PRIVIA HEALTH GROUP INC N/A PRIVIA HEALTH GROUP INC 0.00000000 74276R102 20072.00000000 NS USD 560410.24000000 0.401287849613 Long EC CORP US N 1 N N N PARAGON 28 INC 254900GM24PT1FMTRP66 PARAGON 28 INC 0.00000000 69913P105 30114.00000000 NS USD 532114.38000000 0.381026291201 Long EC CORP US N 1 N N N VAXCYTE INC 254900M7NMHTGASX8D95 VAXCYTE INC 0.00000000 92243G108 10523.00000000 NS USD 505735.38000000 0.362137321248 Long EC CORP US N 1 N N N APPFOLIO INC - A 529900OOUUGT6JFC0S15 APPFOLIO INC - A 0.00000000 03783C100 10548.00000000 NS USD 1904863.32000000 1.363998105192 Long EC CORP US N 1 N N N 908 DEVICES INC N/A 908 DEVICES INC 0.00000000 65443P102 187978.00000000 NS USD 1308326.88000000 0.936841697015 Long EC CORP US N 1 N N N PERSONALIS INC N/A PERSONALIS INC 0.00000000 71535D106 126736.00000000 NS USD 299096.96000000 0.214171632381 Long EC CORP US N 1 N N N VEEVA SYSTEMS INC-CLASS A 549300YZEXPDB92M2F02 VEEVA SYSTEMS INC-CLASS A 0.00000000 922475108 11492.00000000 NS USD 2346896.24000000 1.680520586874 Long EC CORP US N 1 N N N WEBSTER FINANCIAL CORP KMRURHT0VWKYS6Z5KU67 WEBSTER FINANCIAL CORP 0.00000000 947890109 27785.00000000 NS USD 1314786.20000000 0.941466963379 Long EC CORP US N 1 N N N KARUNA THERAPEUTICS INC N/A KARUNA THERAPEUTICS INC 0.00000000 48576A100 5952.00000000 NS USD 1189031.04000000 0.851418612845 Long EC CORP US N 1 N N N BIO-TECHNE CORP 54930073RLKQ51TILZ35 BIO-TECHNE CORP 0.00000000 09073M104 51271.00000000 NS USD 4276001.40000000 3.061877325349 Long EC CORP US N 1 N N N LEGALZOOMCOM INC N/A LEGALZOOMCOM INC 0.00000000 52466B103 60985.00000000 NS USD 931850.80000000 0.667261903873 Long EC CORP US N 1 N N N VERTEX INC - CLASS A 549300QMYW171MP1PL50 VERTEX INC - CLASS A 0.00000000 92538J106 82416.00000000 NS USD 1710956.16000000 1.225148773564 Long EC CORP US N 1 N N N SEMRUSH HOLDINGS INC-A N/A SEMRUSH HOLDINGS INC-A 0.00000000 81686C104 41737.00000000 NS USD 442829.57000000 0.317092931582 Long EC CORP US N 1 N N N UNIVERSAL DISPLAY CORP N/A UNIVERSAL DISPLAY CORP 0.00000000 91347P105 6648.00000000 NS USD 969810.24000000 0.694443173883 Long EC CORP US N 1 N N N VICTORIA'S SECRET & CO 5493006T3O70U3UWVF17 VICTORIA'S SECRET & CO 0.00000000 926400102 21552.00000000 NS USD 441600.48000000 0.316212828315 Long EC CORP US N 1 N N N REPLIGEN CORP 54930006QJ0T5AUO1E71 REPLIGEN CORP 0.00000000 759916109 9649.00000000 NS USD 1655382.44000000 1.185354606716 Long EC CORP US N 1 N N N BJ'S WHOLESALE CLUB HOLDINGS 549300UCIWH1C93V0J03 BJ'S WHOLESALE CLUB HOLDINGS 0.00000000 05550J101 50157.00000000 NS USD 3325910.67000000 2.381554521149 Long EC CORP US N 1 N N N NEOGEN CORP 549300HJT9FC36N4UW43 NEOGEN CORP 0.00000000 640491106 61064.00000000 NS USD 1416074.16000000 1.013995309149 Long EC CORP US N 1 N N N ATMUS FILTRATION TECHNOLOGIE N/A ATMUS FILTRATION TECHNOLOGIE 0.00000000 04956D107 1847.00000000 NS USD 44050.95000000 0.031543162021 Long EC CORP US N 1 N N N INSULET CORP 549300TZTYD2PYN92D43 INSULET CORP 0.00000000 45784P101 10926.00000000 NS USD 3023770.50000000 2.165203765137 Long EC CORP US N 1 N N N TOLERO DCR N/A TOLERO DCR 0.00000000 N/A 528559.00000000 NS USD 364705.71000000 0.261151491642 Long EC CORP US Y 3 N N N CAVA GROUP INC N/A CAVA GROUP INC 0.00000000 148929102 5545.00000000 NS USD 316674.95000000 0.226758543369 Long EC CORP US N 1 N N N ICON PLC 6354008SRQGEMC4XFI67 ICON PLC 0.00000000 G4705A100 7793.00000000 NS USD 1959238.13000000 1.402933779490 Long EC CORP IE N 1 N N N MOONLAKE IMMUNOTHERAPEUTICS N/A MOONLAKE IMMUNOTHERAPEUTICS 0.00000000 61559X104 22403.00000000 NS USD 1362326.43000000 0.975508662308 Long EC CORP CH N 1 N N N TANGER FACTORY OUTLET CENTER UKEW8YSXE4Y581KYOL30 TANGER FACTORY OUTLET CENTER 0.00000000 875465106 110050.00000000 NS USD 2576270.50000000 1.844766521338 Long RE CORP US N 1 N N N GUIDEWIRE SOFTWARE INC 549300WXSG0J8IXZCK32 GUIDEWIRE SOFTWARE INC 0.00000000 40171V100 17034.00000000 NS USD 1444823.88000000 1.034581858952 Long EC CORP US N 1 N N N CROSSLINK VENTURES C LLC N/A CROSSLINK VENTURES C LLC CLASS B SHARES 0.00000000 N/A 13.00000000 NS USD 340548.00000000 0.243853100561 Long EC CORP US Y 3 N N N EVERBRIDGE INC 549300WCY0UMR64ATW81 EVERBRIDGE INC 0.00000000 29978A104 42067.00000000 NS USD 1297346.28000000 0.928978918916 Long EC CORP US N 1 N N N SPS COMMERCE INC 2549006XVF9GCCETDQ72 SPS COMMERCE INC 0.00000000 78463M107 29903.00000000 NS USD 5394202.17000000 3.862577152728 Long EC CORP US N 1 N N N 2023-08-30 Alger Institutional Funds Sergio Pavone Sergio Pavone Assistant Treasurer XXXX GRAPHIC 2 img001.jpg SOI_IMG begin 644 img001.jpg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

 

 

 

THE ALGER INSTITUTIONAL FUNDS

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—100.0%   SHARES     VALUE  
ADVERTISING—0.9%            
The Trade Desk, Inc., Cl. A*     214,103     $ 19,539,040  
AEROSPACE & DEFENSE—2.9%            
HEICO Corp.     99,930       17,585,681  
TransDigm Group, Inc.     50,541       45,472,749  
              63,058,430  
AGRICULTURAL & FARM MACHINERY—0.4%            
Deere & Co.     19,515       8,383,644  
APPAREL ACCESSORIES & LUXURY GOODS—0.5%            
LVMH Moet Hennessy Louis Vuitton SE     11,894       11,046,766  
APPLICATION SOFTWARE—4.3%            
Adobe, Inc.*     56,851       31,050,311  
Cadence Design Systems, Inc.*     64,628       15,123,598  
Datadog, Inc., Cl. A*     143,962       16,803,245  
Intuit, Inc.     37,785       19,334,584  
Salesforce, Inc.*     45,919       10,332,234  
              92,643,972  
AUTOMOBILE MANUFACTURERS—1.7%            
Tesla, Inc.*     135,043       36,114,549  
AUTOMOTIVE PARTS & EQUIPMENT—0.4%            
Mobileye Global, Inc., Cl. A*     223,725       8,541,820  
BIOTECHNOLOGY—2.6%            
Natera, Inc.*     541,535       24,488,213  
Vaxcyte, Inc.*     412,593       19,829,219  
Vertex Pharmaceuticals, Inc.*     32,961       11,613,479  
              55,930,911  
BROADLINE RETAIL—8.1%            
Amazon.com, Inc.*     1,018,236       136,117,789  
MercadoLibre, Inc.*     31,041       38,430,310  
              174,548,099  
CARGO GROUND TRANSPORTATION—0.3%            
Old Dominion Freight Line, Inc.     17,803       7,468,180  
CASINOS & GAMING—3.7%            
DraftKings, Inc., Cl. A*     516,986       16,429,815  
Flutter Entertainment PLC*     120,028       23,873,514  
Las Vegas Sands Corp.*     387,584       23,181,399  
MGM Resorts International     315,848       16,035,603  
              79,520,331  
CONSTRUCTION & ENGINEERING—0.4%            
Quanta Services, Inc.     39,826       8,029,718  
CONSTRUCTION MACHINERY & HEAVY TRANSPORTATION EQUIPMENT—0.5%              
Wabtec Corp.     91,275       10,810,611  
CONSTRUCTION MATERIALS—1.4%            
Martin Marietta Materials, Inc.     67,225       30,013,273  
DIVERSIFIED BANKS—1.1%            
JPMorgan Chase & Co.     142,926       22,576,591  
ELECTRICAL COMPONENTS & EQUIPMENT—0.4%            
Eaton Corp. PLC     44,249       9,085,205  

 

- 2 - 

THE ALGER INSTITUTIONAL FUNDS

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—100.0% (CONT.)   SHARES     VALUE  
ENVIRONMENTAL & FACILITIES SERVICES—1.1%            
GFL Environmental, Inc.     681,704     $ 23,273,375  
FINANCIAL EXCHANGES & DATA—2.1%            
CME Group, Inc., Cl. A     62,704       12,475,588  
S&P Global, Inc.     79,866       31,507,935  
              43,983,523  
HEALTHCARE DISTRIBUTORS—0.9%            
McKesson Corp.     46,496       18,709,990  
HEALTHCARE EQUIPMENT—3.1%            
Boston Scientific Corp.*     439,489       22,787,505  
Dexcom, Inc.*     111,485       13,886,571  
GE HealthCare Technologies, Inc.     119,034       9,284,652  
Intuitive Surgical, Inc.*     65,178       21,143,743  
              67,102,471  
HEALTHCARE FACILITIES—0.8%            
Acadia Healthcare Co., Inc.*     213,022       16,835,129  
HOTELS RESORTS & CRUISE LINES—1.7%            
Booking Holdings, Inc.*     3,976       11,811,901  
Trip.com Group Ltd.#,*     593,113       24,341,357  
              36,153,258  
INDUSTRIAL GASES—0.5%            
Air Products & Chemicals, Inc.     36,240       11,065,159  
INTERACTIVE MEDIA & SERVICES—9.3%            
Alphabet, Inc., Cl. C*     718,171       95,595,742  
Meta Platforms, Inc., Cl. A*     306,118       97,529,195  
Pinterest, Inc., Cl. A*     194,908       5,650,383  
              198,775,320  
INTERNET SERVICES & INFRASTRUCTURE—0.4%            
MongoDB, Inc., Cl. A*     21,912       9,277,541  
LIFE SCIENCES TOOLS & SERVICES—1.1%            
Danaher Corp.     92,589       23,615,750  
MANAGED HEALTHCARE—1.2%            
UnitedHealth Group, Inc.     52,593       26,631,517  
MOVIES & ENTERTAINMENT—2.3%            
Liberty Media Corp. Series C Liberty Formula One*     179,591       13,038,307  
Netflix, Inc.*     80,569       35,367,374  
              48,405,681  
OIL & GAS EQUIPMENT & SERVICES—1.1%            
Schlumberger NV     386,135       22,527,116  
OIL & GAS EXPLORATION & PRODUCTION—2.0%            
Diamondback Energy, Inc.     101,559       14,961,672  
Hess Corp.     87,095       13,214,924  
Pioneer Natural Resources Co.     66,461       14,998,254  
              43,174,850  
OIL & GAS STORAGE & TRANSPORTATION—0.5%            
Cheniere Energy, Inc.     68,938       11,158,305  
PASSENGER GROUND TRANSPORTATION—0.5%            
Uber Technologies, Inc.*     235,867       11,665,982  

 

- 3 - 

THE ALGER INSTITUTIONAL FUNDS 

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—100.0% (CONT.)   SHARES     VALUE  
PHARMACEUTICALS—1.6%            
AstraZeneca PLC#     194,803     $ 13,967,375  
Eli Lilly & Co.     24,808       11,276,476  
Reata Pharmaceuticals, Inc., Cl. A*     49,844       8,253,170  
              33,497,021  
SEMICONDUCTORS—13.2%            
Advanced Micro Devices, Inc.*     143,114       16,372,242  
Broadcom, Inc.     4,703       4,226,351  
First Solar, Inc.*     51,462       10,673,219  
Marvell Technology, Inc.     617,287       40,203,902  
NVIDIA Corp.     369,643       172,730,477  
ON Semiconductor Corp.*     96,205       10,366,089  
Taiwan Semiconductor Manufacturing Co., Ltd.#     278,571       27,620,315  
              282,192,595  
SPECIALTY CHEMICALS—0.9%            
Albemarle Corp.     86,207       18,300,022  
SYSTEMS SOFTWARE—14.9%            
Microsoft Corp.     835,512       280,665,191  
Oracle Corp.     151,613       17,773,592  
Palo Alto Networks, Inc.*     6,037       1,509,009  
ServiceNow, Inc.*     34,249       19,967,167  
              319,914,959  
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—7.5%            
Apple, Inc.     820,289       161,145,774  
TRANSACTION & PAYMENT PROCESSING SERVICES—3.7%            
Toast, Inc., Cl. A*     487,088       10,750,032  
Visa, Inc., Cl. A     287,306       68,301,256  
              79,051,288  
TOTAL COMMON STOCKS                
(Cost $1,158,486,654)             2,143,767,766  

 

PREFERRED STOCKS—0.1%     SHARES       VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—0.1%            
Chime Financial, Inc., Series G*,@,(a)     38,919       1,670,014  
(Cost $2,688,128)             1,670,014  

 

SPECIAL PURPOSE VEHICLE—0.1%             VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—0.1%            
Crosslink Ventures Capital C, LLC, Cl. A*,@,(a),(b)             3,203,289  
(Cost $3,075,000)             3,203,289  
Total Investments                
(Cost $1,164,249,782)     100.2 %   $ 2,148,641,069  
Affiliated Securities (Cost $3,075,000)             3,203,289  
Unaffiliated Securities (Cost $1,161,174,782)             2,145,437,780  
Liabilities in Excess of Other Assets     (0.2 )%     (4,892,904 )
NET ASSETS     100.0 %   $ 2,143,748,165  

 

# American Depositary Receipts.

 

- 4 -

THE ALGER INSTITUTIONAL FUNDS 

ALGER CAPITAL APPRECIATION INSTITUTIONAL FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).

(b) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.

* Non-income producing security.

@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Chime Financial, Inc., Series G   8/24/21   $ 2,688,128       0.06%     $ 1,670,014       0.08 %
Crosslink Ventures Capital C, LLC, Cl. A   10/2/20     3,075,000       0.08%       3,203,289       0.15 %
Total                       $ 4,873,303       0.23 %

 

See Notes to Financial Statements.

 

- 5 -

THE ALGER INSTITUTIONAL FUNDS │ALGER FOCUS EQUITY FUND 

Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—99.4%   SHARES     VALUE  
ADVERTISING—0.9%              
The Trade Desk, Inc., Cl. A*     126,173      $ 11,514,548  
AEROSPACE & DEFENSE—2.6%              
TransDigm Group, Inc.     37,807       34,015,714  
APPAREL ACCESSORIES & LUXURY GOODS—0.5%              
LVMH Moet Hennessy Louis Vuitton SE     7,317       6,795,795  
APPLICATION SOFTWARE—4.5%              
Adobe, Inc.*     47,332       25,851,318  
Datadog, Inc., Cl. A*     123,736       14,442,466  
Intuit, Inc.     22,621       11,575,166  
Salesforce, Inc.*     35,099       7,897,626  
              59,766,576  
AUTOMOBILE MANUFACTURERS—1.7%              
Tesla, Inc.*     83,944       22,449,144  
AUTOMOTIVE PARTS & EQUIPMENT—0.8%              
Mobileye Global, Inc., Cl. A*     277,214       10,584,030  
BIOTECHNOLOGY—2.2%              
Natera, Inc.*     382,877       17,313,698  
Vaxcyte, Inc.*     260,149       12,502,761  
              29,816,459  
BROADLINE RETAIL—7.3%              
Amazon.com, Inc.*     545,373       72,905,463  
MercadoLibre, Inc.*     19,520       24,166,736  
              97,072,199  
CASINOS & GAMING—3.6%              
DraftKings, Inc., Cl. A*     356,748       11,337,451  
Flutter Entertainment PLC*     128,555       25,569,531  
MGM Resorts International     220,569       11,198,288  
              48,105,270  
CONSTRUCTION MACHINERY & HEAVY TRANSPORTATION EQUIPMENT—1.0%              
Wabtec Corp.     108,659       12,869,572  
CONSTRUCTION MATERIALS—2.0%              
Martin Marietta Materials, Inc.     60,418       26,974,220  
DIVERSIFIED BANKS—1.1%              
JPMorgan Chase & Co.     89,317       14,108,513  
ELECTRICAL COMPONENTS & EQUIPMENT—1.0%              
Eaton Corp. PLC     24,120       4,952,318  
Vertiv Holdings Co., Cl. A     306,054       7,960,465  
              12,912,783  
ENVIRONMENTAL & FACILITIES SERVICES—2.6%              
GFL Environmental, Inc.     1,009,628       34,468,700  
FINANCIAL EXCHANGES & DATA—2.8%              
CME Group, Inc., Cl. A     68,699       13,668,353  
S&P Global, Inc.     58,551       23,098,955  
              36,767,308  
HEALTHCARE DISTRIBUTORS—1.0%              
McKesson Corp.     34,187       13,756,849  

 

- 6 - 

THE ALGER INSTITUTIONAL FUNDS│ ALGER FOCUS EQUITY FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—99.4% (CONT.)   SHARES     VALUE  
HEALTHCARE EQUIPMENT—4.1%            
Boston Scientific Corp.*     301,316     $ 15,623,235  
GE HealthCare Technologies, Inc.     82,197       6,411,366  
TransMedics Group, Inc.*     343,041       31,964,560  
              53,999,161  
HEALTHCARE FACILITIES—1.0%            
Acadia Healthcare Co., Inc.*     174,820       13,816,025  
HOTELS RESORTS & CRUISE LINES—1.3%            
Trip.com Group Ltd.#,*     423,257       17,370,467  
INDUSTRIAL GASES—0.8%            
Air Products & Chemicals, Inc.     37,125       11,335,376  
INTERACTIVE MEDIA & SERVICES—9.2%            
Alphabet, Inc., Cl. C*     449,291       59,805,125  
Meta Platforms, Inc., Cl. A*     196,833       62,710,994  
              122,516,119  
LIFE SCIENCES TOOLS & SERVICES—0.9%            
Danaher Corp.     45,206       11,530,242  
MANAGED HEALTHCARE—1.8%            
UnitedHealth Group, Inc.     46,539       23,565,953  
MOVIES & ENTERTAINMENT—3.1%            
Liberty Media Corp. Series C Liberty Formula One*     271,711       19,726,219  
Netflix, Inc.*     48,982       21,501,628  
              41,227,847  
OIL & GAS EQUIPMENT & SERVICES—1.2%            
Schlumberger NV     269,837       15,742,291  
OIL & GAS EXPLORATION & PRODUCTION—2.6%            
EOG Resources, Inc.     263,105       34,869,306  
PHARMACEUTICALS—0.9%            
AstraZeneca PLC#     170,078       12,194,593  
SEMICONDUCTORS—13.1%            
Advanced Micro Devices, Inc.*     87,988       10,065,827  
First Solar, Inc.*     36,331       7,535,049  
Marvell Technology, Inc.     429,874       27,997,694  
NVIDIA Corp.     224,233       104,781,839  
ON Semiconductor Corp.*     76,309       8,222,295  
Taiwan Semiconductor Manufacturing Co., Ltd.#     159,002       15,765,048  
              174,367,752  
SYSTEMS SOFTWARE—13.3%            
Microsoft Corp.     485,324       163,030,038  
ServiceNow, Inc.*     23,270       13,566,410  
              176,596,448  
TECHNOLOGY HARDWARE STORAGE & PERIPHERALS—6.9%            
Apple, Inc.     464,699       91,290,118  
TRANSACTION & PAYMENT PROCESSING SERVICES—3.6%            
Visa, Inc., Cl. A     202,234       48,077,089  
TOTAL COMMON STOCKS                
(Cost $899,202,246)           1,320,476,467  

- 7 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER FOCUS EQUITY FUND 

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

PREFERRED STOCKS—0.0%   SHARES     VALUE  
BIOTECHNOLOGY—0.0%            
Prosetta Biosciences, Inc., Series D*,@,(a),(b)     76,825     $ —    
(Cost $345,713)             —    
Total Investments                
(Cost $899,547,959)     99.4 %   $ 1,320,476,467  
Affiliated Securities (Cost $345,713)             —    
Unaffiliated Securities (Cost $899,202,246)             1,320,476,467  
Other Assets in Excess of Liabilities     0.6 %     8,525,341  
NET ASSETS     100.0 %   $ 1,329,001,808  

 

# American Depositary Receipts.
(a) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.
(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).
* Non-income producing security.
@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Prosetta Biosciences, Inc., Series D   2/6/15   $ 345,713       0.80%     $ 0       0.00 %
Total                       $ 0       0.00 %

 

See Notes to Financial Statements.

 

- 8 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—97.4%   SHARES     VALUE  
ADVERTISING—2.6%            
The Trade Desk, Inc., Cl. A*     18,176     $ 1,658,742  
AEROSPACE & DEFENSE—4.6%            
HEICO Corp.     7,999       1,407,664  
TransDigm Group, Inc.     1,725       1,552,017  
              2,959,681  
APPAREL ACCESSORIES & LUXURY GOODS—0.5%            
Lululemon Athletica, Inc.*     772       292,225  
APPLICATION SOFTWARE—11.8%            
Bill.com Holdings, Inc.*     3,656       458,243  
Cadence Design Systems, Inc.*     4,120       964,121  
Constellation Software, Inc.     638       1,347,722  
Datadog, Inc., Cl. A*     11,813       1,378,813  
Guidewire Software, Inc.*     11,973       1,015,550  
Manhattan Associates, Inc.*     4,759       907,161  
Procore Technologies, Inc.*     7,251       549,988  
The Descartes Systems Group, Inc.*     11,763       917,333  
              7,538,931  
ASSET MANAGEMENT & CUSTODY BANKS—1.6%            
Ares Management Corp., Cl. A     10,620       1,053,716  
AUTOMOTIVE PARTS & EQUIPMENT—0.8%            
Mobileye Global, Inc., Cl. A*     13,413       512,108  
AUTOMOTIVE RETAIL—1.6%            
AutoZone, Inc.*     402       997,651  
BIOTECHNOLOGY—3.1%            
Apellis Pharmaceuticals, Inc.*     1,646       42,385  
Celldex Therapeutics, Inc.*     9,919       350,736  
Natera, Inc.*     26,710       1,207,826  
Vaxcyte, Inc.*     8,233       395,678  
              1,996,625  
BUILDING PRODUCTS—0.7%            
Trex Co., Inc.*     6,758       467,248  
CARGO GROUND TRANSPORTATION—2.2%            
Old Dominion Freight Line, Inc.     3,383       1,419,135  
CONSTRUCTION & ENGINEERING—1.6%            
WillScot Mobile Mini Holdings Corp.*     20,857       1,000,093  
CONSTRUCTION MACHINERY & HEAVY TRANSPORTATION EQUIPMENT—1.5%              
Wabtec Corp.     8,278       980,446  
CONSTRUCTION MATERIALS—2.2%            
Martin Marietta Materials, Inc.     3,085       1,377,329  
CONSUMER STAPLES MERCHANDISE RETAIL—0.8%            
BJ’s Wholesale Club Holdings, Inc.*     7,985       529,485  
ELECTRONIC COMPONENTS—2.0%            
Amphenol Corp., Cl. A     14,128       1,247,644  
ELECTRONIC EQUIPMENT & INSTRUMENTS—1.5%            
Novanta, Inc.*     5,536       979,318  
ENVIRONMENTAL & FACILITIES SERVICES—3.3%            
GFL Environmental, Inc.     61,325       2,093,636  

 

- 9 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—97.4% (CONT.)   SHARES   VALUE
FINANCIAL EXCHANGES & DATA—2.5%            
MSCI, Inc., Cl. A     2,953     $ 1,618,480  
HEALTHCARE EQUIPMENT—6.9%            
Dexcom, Inc.*     9,974       1,242,362  
IDEXX Laboratories, Inc.*     2,784       1,544,368  
Insulet Corp.*     2,977       823,885  
Teleflex, Inc.     3,143       789,427  
              4,400,042  
HEALTHCARE FACILITIES—1.7%            
Acadia Healthcare Co., Inc.*     13,964       1,103,575  
HEALTHCARE TECHNOLOGY—1.7%            
Veeva Systems, Inc., Cl. A*     5,311       1,084,612  
HOME IMPROVEMENT RETAIL—2.0%            
Floor & Decor Holdings, Inc., Cl. A*     10,940       1,256,459  
HOMEBUILDING—1.8%            
NVR, Inc.*     186       1,172,998  
HOTELS RESORTS & CRUISE LINES—1.8%            
Hilton Worldwide Holdings, Inc.     7,364       1,145,028  
HUMAN RESOURCE & EMPLOYMENT SERVICES—1.8%            
Paycom Software, Inc.     3,180       1,172,657  
INSURANCE BROKERS—0.9%            
Ryan Specialty Holdings, Inc., Cl. A*     13,751       595,968  
INTERACTIVE MEDIA & SERVICES—0.7%            
Pinterest, Inc., Cl. A*     16,452       476,944  
INTERNET SERVICES & INFRASTRUCTURE—2.2%            
MongoDB, Inc., Cl. A*     3,357       1,421,354  
IT CONSULTING & OTHER SERVICES—1.5%            
Globant SA*     5,425       947,910  
LIFE SCIENCES TOOLS & SERVICES—5.8%            
Mettler-Toledo International, Inc.*     644       809,811  
Repligen Corp.*     7,401       1,269,715  
West Pharmaceutical Services, Inc.     4,492       1,653,236  
              3,732,762  
METAL, GLASS & PLASTIC CONTAINERS—0.7%            
Ball Corp.     7,629       447,746  
MOVIES & ENTERTAINMENT—1.8%            
Liberty Media Corp. Series C Liberty Formula One*     13,737       997,306  
Live Nation Entertainment, Inc.*     1,705       149,614  
              1,146,920  
OIL & GAS EXPLORATION & PRODUCTION—2.7%            
Diamondback Energy, Inc.     11,953       1,760,916  
OTHER SPECIALTY RETAIL—0.5%            
Five Below, Inc.*     1,534       319,594  
PROPERTY & CASUALTY INSURANCE—1.4%            
Intact Financial Corp.     5,888       869,728  
REAL ESTATE SERVICES—4.8%            
CoStar Group, Inc.*     12,810       1,075,656  
FirstService Corp.     12,878       2,017,081  
              3,092,737  

- 10 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—97.4% (CONT.)   SHARES   VALUE
RESEARCH & CONSULTING SERVICES—2.8%            
TransUnion     9,847     $ 784,707  
Verisk Analytics, Inc., Cl. A     4,391       1,005,276  
              1,789,983  
RESTAURANTS—3.2%            
Chipotle Mexican Grill, Inc., Cl. A*     499       979,178  
Domino’s Pizza, Inc.     2,750       1,091,035  
              2,070,213  
SEMICONDUCTOR MATERIALS & EQUIPMENT—0.5%            
KLA Corp.     641       329,442  
SEMICONDUCTORS—5.3%            
Lattice Semiconductor Corp.*     6,103       555,007  
Marvell Technology, Inc.     23,443       1,526,843  
ON Semiconductor Corp.*     12,434       1,339,764  
              3,421,614  
TOTAL COMMON STOCKS                
(Cost $52,480,521)             62,481,695  
                 
PREFERRED STOCKS—0.0%     SHARES       VALUE  
BIOTECHNOLOGY—0.0%            
Prosetta Biosciences, Inc., Series D*,@,(a),(b)     166,009       —    
(Cost $747,040)             —    
                 
RIGHTS—0.5%     SHARES       VALUE  
BIOTECHNOLOGY—0.5%            
Tolero CDR*,@,(b),(c)     422,928       291,820  
(Cost $226,186)             291,820  
                 
SPECIAL PURPOSE VEHICLE—1.3%             VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—1.3%            
Crosslink Ventures Capital C, LLC, Cl. A*,@,(a),(b)             572,946  
Crosslink Ventures Capital C, LLC, Cl. B*,@,(a),(b)             235,764  
              808,710  
TOTAL SPECIAL PURPOSE VEHICLE                
(Cost $775,000)             808,710  
Total Investments                
(Cost $54,228,747)     99.2 %   $ 63,582,225  
Affiliated Securities (Cost $1,522,040)             808,710  
Unaffiliated Securities (Cost $52,706,707)             62,773,515  
Other Assets in Excess of Liabilities     0.8 %     484,125  
NET ASSETS     100.0 %   $ 64,066,350  

 

(a) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.

(b) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).

(c) Contingent Deferred Rights.

* Non-income producing security.

- 11 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER MID CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Crosslink Ventures Capital C, LLC, Cl. A   10/2/20   $ 550,000       0.50%     $ 572,946       0.89 %
Crosslink Ventures Capital C, LLC, Cl. B   12/16/20     225,000       0.19%       235,764       0.37 %
Prosetta Biosciences, Inc., Series D   2/6/15     747,040       0.50%       0       0.00 %
Tolero CDR   2/6/17     226,186       0.23%       291,820       0.46 %
Total                       $ 1,100,530       1.72 %

 

See Notes to Financial Statements.

- 12 - 

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited)

 

 

COMMON STOCKS—92.4%   SHARES     VALUE  
ADVERTISING—0.6%                
Magnite, Inc.*     58,652     $ 887,405  
AEROSPACE & DEFENSE—4.4%                
HEICO Corp.     22,096       3,888,454  
Hexcel Corp.     10,920       771,826  
Mercury Systems, Inc.*     38,152       1,449,013  
              6,109,293  
APPAREL ACCESSORIES & LUXURY GOODS—1.1%                
Capri Holdings Ltd.*     41,136       1,518,330  
APPAREL RETAIL—0.5%                
Aritzia, Inc.*     10,957       208,448  
Victoria’s Secret & Co.*     21,552       441,600  
              650,048  
APPLICATION SOFTWARE—24.0%                
ACI Worldwide, Inc.*     62,376       1,446,500  
AppFolio, Inc., Cl. A*     10,548       1,904,863  
Bill.com Holdings, Inc.*     19,264       2,414,550  
Blackbaud, Inc.*     21,038       1,587,317  
Blackline, Inc.*     29,917       1,737,579  
Everbridge, Inc.*     42,067       1,297,346  
Guidewire Software, Inc.*     17,034       1,444,824  
HubSpot, Inc.*     6,842       3,972,123  
Manhattan Associates, Inc.*     27,197       5,184,292  
Q2 Holdings, Inc.*     48,569       1,722,743  
SEMrush Holdings, Inc., Cl. A*     41,737       442,830  
Smartsheet, Inc., Cl. A*     31,943       1,418,269  
Sprout Social, Inc., Cl. A*     30,878       1,764,369  
SPS Commerce, Inc.*     29,903       5,394,202  
Vertex, Inc., Cl. A*     82,416       1,710,956  
              33,442,763  
ASSET MANAGEMENT & CUSTODY BANKS—0.4%                
Affiliated Managers Group, Inc.     4,469       619,582  
AUTOMOTIVE PARTS & EQUIPMENT—0.0%                
Atmus Filtration Technologies, Inc.*     1,847       44,051  
BIOTECHNOLOGY—6.6%                
ACELYRIN, Inc.*     11,317       281,114  
ADMA Biologics, Inc.*     208,870       866,810  
Alkermes PLC*     16,590       485,755  
Arcus Biosciences, Inc.*     17,175       341,783  
Avidity Biosciences, Inc.*     29,546       280,982  
Cabaletta Bio, Inc.*     114,375       1,557,788  
Celldex Therapeutics, Inc.*     21,328       754,158  
Karuna Therapeutics, Inc.*     5,952       1,189,031  
MoonLake Immunotherapeutics, Cl. A*     22,403       1,362,326  
Morphic Holding, Inc.*     14,724       835,293  
RAPT Therapeutics, Inc.*     30,555       730,265  
Vaxcyte, Inc.*     10,523       505,735  
              9,191,040  
- 13 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—92.4% (CONT.)   SHARES     VALUE  
CONSUMER STAPLES MERCHANDISE RETAIL—2.4%                
BJ’s Wholesale Club Holdings, Inc.*     50,157     $ 3,325,911  
DIVERSIFIED SUPPORT SERVICES—0.5%                
RB Global, Inc.     9,766       629,712  
ELECTRICAL COMPONENTS & EQUIPMENT—0.4%                
Sunrun, Inc.*     32,054       608,385  
ELECTRONIC EQUIPMENT & INSTRUMENTS—0.9%                
908 Devices, Inc.*     187,978       1,308,327  
FOOD DISTRIBUTORS—3.2%                
The Chefs’ Warehouse, Inc.*     40,013       1,454,072  
US Foods Holding Corp.*     68,800       2,939,824  
              4,393,896  
FOOTWEAR—0.6%                
On Holding AG, Cl. A*     22,379       805,644  
HEALTHCARE DISTRIBUTORS—0.3%                
PetIQ, Inc., Cl. A*     25,789       431,708  
HEALTHCARE EQUIPMENT—8.2%                
Impulse Dynamics PLC, Class E*,@,(a)     532,406       1,756,940  
Inmode Ltd.*     37,353       1,602,817  
Insulet Corp.*     10,926       3,023,771  
Paragon 28, Inc.*     30,114       532,114  
QuidelOrtho Corp.*     32,314       2,822,951  
Shockwave Medical, Inc.*     2,483       647,070  
Tandem Diabetes Care, Inc.*     30,237       1,055,876  
              11,441,539  
HEALTHCARE SERVICES—0.4%                
Privia Health Group, Inc.*     20,072       560,410  
HEALTHCARE SUPPLIES—1.0%                
Neogen Corp.*     61,064       1,416,074  
HEALTHCARE TECHNOLOGY—1.9%                
Doximity, Inc., Cl. A*     7,724       275,979  
Veeva Systems, Inc., Cl. A*     11,492       2,346,896  
              2,622,875  
HOMEBUILDING—0.5%                
Skyline Champion Corp.*     9,683       674,518  
HUMAN RESOURCE & EMPLOYMENT SERVICES—0.7%                
Paycom Software, Inc.     2,624       967,626  
INDUSTRIAL MACHINERY & SUPPLIES & COMPONENTS—0.7%                
Gates Industrial Corp., PLC*     68,151       928,217  
INTERACTIVE HOME ENTERTAINMENT—1.6%                
Take-Two Interactive Software, Inc.*     14,524       2,221,301  
INTERACTIVE MEDIA & SERVICES—0.8%                
Bumble, Inc., Cl. A*     28,543       528,617  
Tripadvisor, Inc.*     33,825       630,836  
              1,159,453  
LEISURE FACILITIES—1.0%                
Planet Fitness, Inc., Cl. A*     21,217       1,432,996  
- 14 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—92.4% (CONT.)   SHARES     VALUE  
LIFE SCIENCES TOOLS & SERVICES—7.6%                
Akoya Biosciences, Inc.*     60,048     $ 414,331  
Bio-Techne Corp.     51,271       4,276,001  
CryoPort, Inc.*     51,379       825,661  
ICON PLC*     7,793       1,959,238  
MaxCyte, Inc.*     80,083       357,971  
Mesa Laboratories, Inc.     3,769       484,920  
NanoString Technologies, Inc.*     63,851       303,931  
Personalis, Inc.*     126,736       299,097  
Repligen Corp.*     9,649       1,655,382  
              10,576,532  
MANAGED HEALTHCARE—1.8%                
HealthEquity, Inc.*     37,533       2,549,992  
MOVIES & ENTERTAINMENT—1.8%                
Live Nation Entertainment, Inc.*     29,285       2,569,759  
OIL & GAS EQUIPMENT & SERVICES—1.3%                
ChampionX Corp.     32,871       1,170,208  
ProPetro Holding Corp.*     67,383       703,478  
              1,873,686  
OIL & GAS EXPLORATION & PRODUCTION—3.3%                
Coterra Energy, Inc.     34,770       957,566  
Magnolia Oil & Gas Corp., Cl. A     162,878       3,607,747  
              4,565,313  
PERSONAL CARE PRODUCTS—0.5%                
Oddity Tech Ltd., Cl. A*     13,730       731,672  
PHARMACEUTICALS—1.4%                
Pliant Therapeutics, Inc.*     22,329       398,349  
Reata Pharmaceuticals, Inc., Cl. A*     6,984       1,156,411  
Ventyx Biosciences, Inc.*     10,465       387,728  
              1,942,488  
REGIONAL BANKS—0.9%                
Webster Financial Corp.     27,785       1,314,786  
RESEARCH & CONSULTING SERVICES—0.7%                
LegalZoom.com, Inc.*     60,985       931,851  
RESTAURANTS—6.6%                
Cava Group, Inc.*     5,545       316,675  
Kura Sushi USA, Inc., Cl. A*     21,124       2,102,049  
Shake Shack, Inc., Cl. A*     29,210       2,268,448  
The Cheesecake Factory, Inc.     33,851       1,245,040  
Wingstop, Inc.     19,374       3,266,069  
              9,198,281  
SEMICONDUCTOR MATERIALS & EQUIPMENT—0.8%                
SolarEdge Technologies, Inc.*     4,446       1,073,531  
SEMICONDUCTORS—0.7%                
Universal Display Corp.     6,648       969,810  
SPECIALTY CHEMICALS—0.3%                
Balchem Corp.     2,834       381,853  
SYSTEMS SOFTWARE—0.4%                
Rapid7, Inc.*     11,833       543,253  
- 15 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND
Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

COMMON STOCKS—92.4% (CONT.)   SHARES     VALUE  
TRADING COMPANIES & DISTRIBUTORS—0.4%                
Xometry, Inc., Cl. A*     27,198     $ 564,630  
TRANSACTION & PAYMENT PROCESSING SERVICES—1.2%                
DLocal Ltd., Cl. A*     70,819       1,074,324  
Marqeta, Inc., Cl. A*     115,506       644,524  
              1,718,848  
TOTAL COMMON STOCKS                
(Cost $96,188,422)             128,897,389  

 

PREFERRED STOCKS—3.5%   SHARES       VALUE
BIOTECHNOLOGY—0.0%                
Prosetta Biosciences, Inc., Series D*,@,(a),(b)     133,263        
DATA PROCESSING & OUTSOURCED SERVICES—3.5%                
Chime Financial, Inc., Series G*,@,(a)     114,399       4,908,861  
TOTAL PREFERRED STOCKS             4,908,861  
(Cost $8,501,200)                

 

RIGHTS—0.3%   SHARES     VALUE  
BIOTECHNOLOGY—0.3%                
Tolero CDR*,@,(a),(c)     528,559       364,706  
(Cost $285,725)             364,706  

 

REAL ESTATE INVESTMENT TRUST—1.8%   SHARES     VALUE  
RETAIL—1.8%                
Tanger Factory Outlet Centers, Inc.     110,050       2,576,270  
(Cost $1,810,916)             2,576,270  

 

SPECIAL PURPOSE VEHICLE—1.2%           VALUE  
DATA PROCESSING & OUTSOURCED SERVICES—1.2%                
Crosslink Ventures Capital C, LLC, Cl. A*,@,(a),(b)             1,328,193  
Crosslink Ventures Capital C, LLC, Cl. B*,@,(a),(b)             340,548  
              1,668,741  
TOTAL SPECIAL PURPOSE VEHICLE             1,668,741  
(Cost $1,600,000)                
Total Investments                
(Cost $108,386,263)     99.2 %   $ 138,415,967  
Affiliated Securities (Cost $2,199,684)             1,668,741  
Unaffiliated Securities (Cost $106,186,579)             136,747,226  
Other Assets in Excess of Liabilities     0.8 %     1,101,587  
NET ASSETS     100.0 %   $ 139,517,554  

 

(a) Security is valued in good faith at fair value determined using significant unobservable inputs pursuant to procedures established by the Valuation Designee (as defined in Note 2).
(b) Deemed an affiliate of the Fund in accordance with Section 2(a)(3) of the Investment Company Act of 1940. See Note 4 - Affiliated Securities.
(c) Contingent Deferred Rights.
* Non-income producing security.
- 16 -

THE ALGER INSTITUTIONAL FUNDS | ALGER SMALL CAP GROWTH INSTITUTIONAL FUND

Schedule of Investments July 31, 2023 (Unaudited) (Continued)

 

 

@ Restricted security - Investment in security not registered under the Securities Act of 1933. Sales or transfers of the investment may be restricted only to qualified buyers.

 

Security  

Acquisition 

Date(s) 

 

Acquisition

Cost

   

% of net assets 

(Acquisition 

Date

 

Market 

Value 

   

% of net assets 

as of

7/31/2023

 
Chime Financial, Inc., Series G   8/24/21   $ 7,901,516       2.12%     $ 4,908,861       3.52 %
Crosslink Ventures Capital C, LLC, Cl. A   10/2/20     1,275,000       0.49%       1,328,193       0.95 %
Crosslink Ventures Capital C, LLC, Cl. B   12/16/20     325,000       0.11%       340,548       0.25 %
Impulse Dynamics PLC, Class E   2/11/22     1,756,940       0.71%       1,756,940       1.26 %
Prosetta Biosciences, Inc., Series D   2/6/15     599,684       0.10%       0       0.00 %
Tolero CDR   2/6/17     285,725       0.16%       364,706       0.26 %
Total                       $ 8,699,248       6.24 %

 

See Notes to Financial Statements.

 

- 17 - 

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited)

 

 

NOTE 1 — General:

 

The Alger Institutional Funds (the “Trust”) is an open-end registered investment company organized as a business trust under the laws of the Commonwealth of Massachusetts. The Trust qualifies as an investment company as defined in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification 946 – Financial Services – Investment Companies. The Trust operates as a series company currently offering an unlimited number of shares of beneficial interest in four series – Alger Capital Appreciation Institutional Fund, Alger Focus Equity Fund, Alger Mid Cap Growth Institutional Fund and Alger Small Cap Growth Institutional Fund (collectively, the “Funds” or individually, each a “Fund”). The Funds normally invest primarily in equity securities and each has an investment objective of long-term capital appreciation.

 

Each Fund offers one or more of the following share classes: Class A, C, I, R, Y, Z and Z-2. Class A shares are generally subject to an initial sales charge while Class C shares are generally subject to a deferred sales charge. Class I, R, Y, Z and Z-2 shares are generally sold to institutional investors and are sold without an initial or deferred sales charge and Class Y, Z and Z-2 shares are generally subject to a minimum initial investment of $500,000. Class C shares will automatically convert to Class A shares on the fifth business day of the month following the eighth anniversary of the purchase date of a shareholder’s Class C shares, without the imposition of any sales load, fee or other charge. Class C shares held at certain dealers may not convert to Class A shares or may be converted on a different schedule. At conversion, a proportionate amount of shares representing reinvested dividends and distributions will also be converted into Class A shares. Effective August 27, 2019, Class C shares were closed to direct shareholders and are only available for purchase through certain financial intermediaries and group retirement plan recordkeeping platforms. Each class has identical rights to assets and earnings, except that each share class bears the pro rata allocation of the Fund’s expenses other than a class expense (not including advisory or custodial fees or other expenses related to the management of the Fund’s assets).

 

On May 23, 2023, the Board of Trustees (the “Board”) approved the transition of the Fund’s custodian and administrator from Brown Brothers Harriman & Company (the “Custodian”) to The Bank of New York Mellon. This change is anticipated to become effective in early 2024.

 

NOTE 2 — Significant Accounting Policies:

 

(a) Investment Valuation: The Funds value their financial instruments at fair value using independent dealers or pricing services under policies approved by the Board of Trustees of the Trust (the “Board”). Investments held by the Funds are valued on each day the New York Stock Exchange (the “NYSE”) is open, as of the close of the NYSE (normally 4:00 p.m. Eastern Time).

 

The Board has designated, pursuant to Rule 2a-5 under the Investment Company Act of 1940, as amended (the “1940 Act”), the Funds’ investment adviser, Fred Alger Management, LLC (“Alger Management” or the “Investment Manager”) as its valuation designee (the “Valuation Designee”) to make fair value determinations subject to the Board’s review and oversight. The Valuation Designee has established a Valuation Committee (“Committee”) comprised of representatives of the Investment Manager and officers of the Funds to assist in performing the duties and responsibilities of the Valuation Designee.

 

- 18 - 

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

The Valuation Designee has established valuation processes including but not limited to: (i) making fair value determinations when market quotations for financial instruments are not readily available in accordance with valuation policies and procedures adopted by the Board; (ii) assessing and managing material risks associated with fair valuation determinations; (iii) selecting, applying and testing fair valuation methodologies; and (iv) overseeing and evaluating pricing services used by the Funds. The Valuation Designee regularly reports its fair valuation determinations and related valuation information to the Board. The Committee generally meets quarterly and on an as-needed basis to review and evaluate the effectiveness of the valuation policies and procedures in accordance with the requirements of Rule 2a-5.

 

Investments in money market funds and short-term securities held by the Funds having a remaining maturity of sixty days or less are valued at amortized cost which approximates market value.

 

Equity securities, including traded rights, warrants and option contracts for which valuation information is readily available, are valued at the last quoted sales price or official closing price on the primary market or exchange on which they are traded as reported by an independent pricing service. In the absence of quoted sales, such securities are generally valued at the bid price or, in the absence of a recent bid price, the equivalent as obtained from one or more of the major market makers for the securities to be valued.

 

Securities in which the Funds invest may be traded in foreign markets that close before the close of the NYSE. Developments that occur between the close of the foreign markets and the close of the NYSE may result in adjustments to the closing foreign prices to reflect what the Valuation Designee, through its Committee, believes to be the fair value of these securities as of the close of the NYSE. The Funds may also fair value securities in other situations, for example, when a particular foreign market is closed but the NYSE is open.

 

FASB Accounting Standards Codification 820 – Fair Value Measurements and Disclosures (“ASC 820”) defines fair value as the price that the Funds would receive upon selling an investment in a timely transaction to an independent buyer in the principal or most advantageous market of the investment. ASC 820 established a three-tier hierarchy to maximize the use of observable market data and minimize the use of unobservable inputs and to establish classification of fair value measurements for disclosure purposes. Inputs refer broadly to the assumptions that market participants would use in pricing the asset or liability and may be observable or unobservable. Observable inputs are based on market data obtained from sources independent of the Funds. Unobservable inputs are inputs that reflect the Funds’ own assumptions based on the best information available in the circumstances. The three-tier hierarchy of inputs is summarized in the three broad Levels listed below.

 

- 19 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Level 1 – quoted prices in active markets for identical investments

 

Level 2 – significant other observable inputs (including quoted prices for similar investments, amortized cost, interest rates, prepayment speeds, credit risk, etc.)

 

Level 3 – significant unobservable inputs (including the Funds’ own assumptions in determining the fair value of investments)

 

The Funds’ valuation techniques are generally consistent with either the market or the income approach to fair value. The market approach considers prices and other relevant information generated by market transactions involving identical or comparable assets to measure fair value. The income approach converts future amounts to a current, or discounted, single amount. These fair value measurements are determined on the basis of the value indicated by current market expectations about such future events. Inputs for Level 1 include exchange-listed prices and broker quotes in an active market. Inputs for Level 2 include the last trade price in the case of a halted security, an exchange-listed price which has been adjusted for fair value factors, and prices of closely related securities. Additional Level 2 inputs include an evaluated price which is based upon a compilation of observable market information such as spreads for fixed income and preferred securities. Inputs for Level 3 include, but are not limited to, revenue multiples, earnings before interest, taxes, depreciation and amortization (“EBITDA”) multiples, discount rates, time to exit and the probabilities of success of certain outcomes. Such unobservable market information may be obtained from a company’s financial statements and from industry studies, market data, and market indicators such as benchmarks and indexes. Because of the inherent uncertainty and often limited markets for restricted securities, the valuations assigned to such securities by the Funds may significantly differ from the valuations that would have been assigned by the Funds had there been an active market for such securities.

 

(b) Cash and Cash Equivalents: Cash and cash equivalents include U.S. dollars, foreign cash and overnight time deposits.

 

NOTE 3 — Fair Value Measurements:

 

The following is a summary of the inputs used as of July 31, 2023 in valuing the Funds’ investments carried at fair value on a recurring basis. Based upon the nature, characteristics, and risks associated with their investments, the Funds have determined that presenting them by security type and sector is appropriate.

 

- 20 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

  

Alger Capital Appreciation                
Institutional Fund   TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
COMMON STOCKS                                
Communication Services   $ 266,720,041     $ 266,720,041     $     $  
Consumer Discretionary     345,924,823       334,878,057       11,046,766        
Energy     76,860,271       76,860,271              
Financials     145,611,402       145,611,402              
Healthcare     242,322,789       242,322,789              
Industrials     141,775,145       141,775,145              
Information Technology     865,174,841       865,174,841              
Materials     59,378,454       59,378,454              
TOTAL COMMON STOCKS   $ 2,143,767,766     $ 2,132,721,000     $ 11,046,766     $  
PREFERRED STOCKS                                
Information Technology     1,670,014                   1,670,014  
SPECIAL PURPOSE VEHICLE                                
Information Technology     3,203,289                   3,203,289  
TOTAL INVESTMENTS IN SECURITIES   $ 2,148,641,069     $ 2,132,721,000     $ 11,046,766     $ 4,873,303  

 

Alger Focus Equity Fund   TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
COMMON STOCKS                                
Communication Services     175,258,514       175,258,514              
Consumer Discretionary     202,376,905       195,581,110       6,795,795        
Energy     50,611,597       50,611,597              
Financials     98,952,910       98,952,910              
Healthcare     158,679,282       158,679,282              
Industrials     94,266,769       94,266,769              
Information Technology     502,020,894       502,020,894              
Materials     38,309,596       38,309,596              
TOTAL COMMON STOCKS   $ 1,320,476,467     $ 1,313,680,672     $ 6,795,795     $  
PREFERRED STOCKS                                
Healthcare     *                 *
TOTAL INVESTMENTS IN SECURITIES   $ 1,320,476,467     $ 1,313,680,672     $ 6,795,795     $  

 

- 21 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Alger Mid Cap Growth Institutional                
Fund   TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
COMMON STOCKS                                
Communication Services   $ 3,282,606     $ 3,282,606     $     $  
Consumer Discretionary     7,766,276       7,766,276              
Consumer Staples     529,485       529,485              
Energy     1,760,916       1,760,916              
Financials     4,137,892       4,137,892              
Healthcare     12,317,616       12,317,616              
Industrials     11,882,879       11,882,879              
Information Technology     15,886,213       15,886,213              
Materials     1,825,075       1,825,075              
Real Estate     3,092,737       3,092,737              
TOTAL COMMON STOCKS   $ 62,481,695     $ 62,481,695     $     $  
PREFERRED STOCKS                                
Healthcare     *                 *
RIGHTS                                
Healthcare     291,820                   291,820  
SPECIAL PURPOSE VEHICLE                                
Information Technology     808,710                   808,710  
TOTAL INVESTMENTS IN SECURITIES   $ 63,582,225     $ 62,481,695     $     $ 1,100,530  

 

Alger Small Cap Growth                                
Institutional Fund     TOTAL       LEVEL 1       LEVEL 2       LEVEL 3  
COMMON STOCKS                                
Communication Services     6,837,918       6,837,918              
Consumer Discretionary     14,323,868       14,323,868              
Consumer Staples     8,451,479       8,451,479              
Energy     6,438,999       6,438,999              
Financials     3,653,216       3,653,216              
Healthcare     40,732,658       38,975,718             1,756,940  
Industrials     10,739,714       10,739,714              
Information Technology     37,337,684       37,337,684              
Materials     381,853       381,853              
TOTAL COMMON STOCKS   $ 128,897,389     $ 127,140,449     $     $ 1,756,940  
PREFERRED STOCKS                                
Healthcare     *                 *
Information Technology     4,908,861                   4,908,861  
TOTAL PREFERRED STOCKS   $ 4,908,861     $     $     $ 4,908,861  
RIGHTS                                
Healthcare     364,706                   364,706  
REAL ESTATE INVESTMENT TRUST                                
Real Estate     2,576,270       2,576,270              
SPECIAL PURPOSE VEHICLE                                
Information Technology     1,668,741                   1,668,741  
TOTAL INVESTMENTS IN SECURITIES   $ 138,415,967     $ 129,716,719     $     $ 8,699,248  

 

* Alger Focus Equity Fund’s, Alger Mid Cap Growth Institutional Fund’s and Alger Small Cap Growth Institutional Fund’s holdings of Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of July 31, 2023.

 

- 22 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund   Common Stocks  
Opening balance at November 1, 2022   $ 585,947  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments     (1,232,569 )
Included in net change in unrealized appreciation (depreciation) on investments     1,880,166  
Purchases and sales        
Purchases      
Sales     (1,233,544 )
Closing balance at July 31, 2023      
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ 1,699,204  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (29,190 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     1,670,014  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (29,190 )

 

- 23 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Capital Appreciation Institutional Fund   Special Purpose
Vehicle
 
Opening balance at November 1, 2022   $ 3,252,120  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (48,831 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     3,203,289  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (48,831 )

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Focus Equity Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ *
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments      
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     *
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

- 24 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Institutional Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ *
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments      
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     *
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Mid Cap Growth Institutional Fund   Rights  
Opening balance at November 1, 2022   $ 253,757  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     38,063  
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     291,820  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ 38,063  

 

- 25 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

   

FAIR VALUE 

MEASUREMENTS 

USING SIGNIFICANT 

UNOBSERVABLE 

INPUTS (LEVEL 3) 

 
    Special Purpose  
Alger Mid Cap Growth Institutional Fund   Vehicle  
Opening balance at November 1, 2022   $ 821,566  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (12,856 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     808,710  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (12,856 )

 

   

FAIR VALUE 

MEASUREMENTS 

USING SIGNIFICANT 

UNOBSERVABLE 

INPUTS (LEVEL 3) 

 
Alger Small Cap Growth Institutional Fund   Common Stocks  
Opening balance at November 1, 2022   $ 1,756,940  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments      
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     1,756,940  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $  

 

- 26 -

THE ALGER INSTITUTIONAL FUNDS 

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

   

FAIR VALUE 

MEASUREMENTS 

USING SIGNIFICANT 

UNOBSERVABLE 

INPUTS (LEVEL 3)

 
Alger Small Cap Growth Institutional Fund   Preferred Stocks  
Opening balance at November 1, 2022   $ 4,994,660 *
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (85,799 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     4,908,861 *
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (85,799 )

 

   

FAIR VALUE

MEASUREMENTS

USING SIGNIFICANT

UNOBSERVABLE

INPUTS (LEVEL 3)

 
Alger Small Cap Growth Institutional Fund   Rights
Opening balance at November 1, 2022   $ 317,135  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     47,571  
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     364,706  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ 47,571  

 

- 27 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

    FAIR VALUE
MEASUREMENTS
USING SIGNIFICANT
UNOBSERVABLE
INPUTS (LEVEL 3)
 
Alger Small Cap Growth Institutional Fund   Special Purpose Vehicle  
Opening balance at November 1, 2022   $ 1,694,942  
Transfers into Level 3      
Transfers out of Level 3      
Total gains or losses        
Included in net realized gain (loss) on investments      
Included in net change in unrealized appreciation (depreciation) on investments     (26,201 )
Purchases and sales        
Purchases      
Sales      
Closing balance at July 31, 2023     1,668,741  
Net change in unrealized appreciation (depreciation) attributable to investments still held at July 31, 2023   $ (26,201 )

 

* Includes securities that are fair valued at zero.

 

The following table provides quantitative information about each Fund’s Level 3 fair value measurements of its investments as of July 31, 2023. The table below is not intended to be all-inclusive, but rather provides information on the Level 3 inputs as they relate to each Fund’s fair value measurements.

 

    Fair Value Valuation Unobservable   Weighted Average
    July 31, 2023 Methodology Input Input/Range Inputs
Alger Capital Appreciation Institutional Fund      
Preferred Stocks $ 1,670,014 Market Approach Revenue Multiple 14.0x-16.0x N/A
Special Purpose Vehicle   3,203,289 Market Approach Revenue Multiple 14.0x-16.0x N/A
             
Alger Focus Equity Fund      
Preferred Stocks   —* Income Approach Discount Rate 100.00% N/A
             
Alger Mid Cap Growth Institutional Fund      
Preferred Stocks   —* Income Approach Discount Rate 100.00% N/A
Rights   291,820 Income Approach Discount Rate
Probability of Success
7.94%-9.43%
0.00%-60.00%
N/A
Special Purpose Vehicle   808,710 Market Approach Revenue Multiple 14.0x-16.0x N/A

 

- 28 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

 

 

Fair Value

July 31, 2023

Valuation

Methodology

Unobservable

Input

Input/Range

Weighted Average

Inputs

Alger Small Cap Growth Institutional Fund          
Common Stocks $ 1,756,940 Market Approach Recent
Transaction Price
N/A N/A
Preferred Stocks   —* Income Approach Discount Rate 100.00 % N/A
Preferred Stocks   4,908,861 Market Approach Revenue Multiple 14.0x-16.0x N/A
Rights   364,706 Income Approach Discount Rate
Probability of Success
7.94%-9.43%
0.00%-60.00%
N/A
Special Purpose Vehicle   1,668,741 Market Approach Revenue Multiple 14.0x-16.0x N/A

 

* Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of July 31, 2023.

 

The significant unobservable inputs used in the fair value measurement of each Fund’s securities are revenue and EBITDA multiples, discount rates, and the probability of success of certain outcomes. Significant increases and decreases in these inputs in isolation and interrelationships between these inputs would have resulted in significantly higher or lower fair value measurements than those noted in the table above. Generally, all other things being equal, increases in revenue and EBITDA multiples, decreases in discount rates, and increases in the probability of success result in higher fair value measurements, whereas decreases in revenues and EBITDA multiples, increases in discount rates, and decreases in the probability of success result in lower fair value measurements.

 

Certain of the Funds’ assets and liabilities are held at carrying amount or face value, which approximates fair value for financial reporting purposes. As of July 31, 2023, such assets were categorized within the ASC 820 disclosure hierarchy as follows:

 

    TOTAL   LEVEL 1   LEVEL 2   LEVEL 3
Cash, foreign cash and cash equivalents                                
Alger Capital Appreciation Institutional Fund     $ 913,721     $ 47     $ 913,674     $  
Alger Focus Equity Fund     7,046,942             7,046,942        
Alger Mid Cap Growth Institutional Fund     1,010,738             1,010,738        
Alger Small Cap Growth Institutional Fund     276,716             276,716        

 

NOTE 4 — Affiliated Securities:

 

During the nine-month period ended July 31, 2023, as disclosed in the following table, certain Funds held 5% or more of the outstanding voting securities of the issuers listed below. As such, these issuers were “affiliated persons” of the applicable Fund(s) for purposes of the 1940 Act. Transactions during the nine-month period ended July 31, 2023 with such affiliated persons are summarized below. During this period, other Funds in the Trust may also have held voting shares of the issuers at levels below 5%.

 

- 29 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Security   Shares
Held at
October 31,
2022
  Shares
Purchased
  Shares
Sold
  Shares
Held at
July 31,
2023
    Dividend
Income
  Realized
Gain (Loss)
  Net Change
in
Unrealized
App(Dep)
  Value at
July 31,
2023
Alger Capital Appreciation Institutional Fund                                                  
Special Purpose Vehicle                                                                
Crosslink Ventures Capital C, LLC, Cl. A***                                   $     $     $ (48,831 )   $ 3,203,289  
Total                     $     $     $ (48,831 )   $ 3,203,289  

 

Security   Shares
Held at
October 31,
2022
    Shares
Purchased
    Shares
Sold
    Shares
Held at
July 31,
2023
    Dividend
Income
    Realized
Gain (Loss)
    Net Change
in
Unrealized
App(Dep)
    Value at
July 31,
2023
 
Alger Focus Equity Fund                                                                
Preferred Stocks                                                                
Prosetta Biosciences, Inc., Series D**     76,825                   76,825     $     $     $     $ *
Total                                   $     $     $     $ *

 

Security   Shares
Held at
October 31,
2022
    Shares
Purchased
   

Shares

Sold

    Shares
Held at
July 31,
2023
    Dividend
Income
    Realized
Gain (Loss)
    Net Change
in
Unrealized
App(Dep)
    Value at
July 31,
2023
 
Alger Mid Cap Growth Institutional Fund                                                                
Preferred Stocks                                                                
Prosetta Biosciences, Inc., Series D**     166,009                   166,009     $     $     $     $ *
Special Purpose Vehicle                                                                
Crosslink Ventures Capital C, LLC, Cl. A***                                                 (8,734 )     572,946  
Crosslink Ventures Capital C, LLC, Cl. B***                                                 (4,122 )     235,764  
Total                                   $     $     $ (12,856 )   $ 808,710  

 

- 30 -

THE ALGER INSTITUTIONAL FUNDS

NOTES TO FINANCIAL STATEMENTS (Unaudited) (Continued)

 

 

Security   Shares
Held at
October 31,
2022
    Shares
Purchased
    Shares
Sold
    Shares
Held at
July 31,
2023
    Dividend
Income
    Realized
Gain (Loss)
    Net Change
in
Unrealized
App(Dep)
    Value at
July 31,
2023
 
Alger Small Cap Growth Institutional Fund                                                                
Preferred Stocks                                                                
Prosetta Biosciences, Inc., Series D**     133,263                   133,263     $     $     $     $ *
Special Purpose Vehicle                                                                
Crosslink Ventures Capital C, LLC, Cl. A***                                                 (20,247 )     1,328,193  
Crosslink Ventures Capital C, LLC, Cl. B***                                                 (5,954 )     340,548  
Total                                   $     $     $ (26,201 )   $ 1,668,741  

 

* Prosetta Biosciences, Inc., Series D shares are classified as a Level 3 investment and are fair valued at zero as of July 31, 2023.

** Prosetta Biosciences, Inc., Series D is deemed to be an affiliate of the Funds because the Funds and Prosetta Biosciences, Inc., Series D are under common control.

*** The Alger Fund Complex and other entities managed by Alger Management fully own Crosslink Ventures Capital C, LLC, Class A and Crosslink Ventures Capital C, LLC, Class B. There were no capital increases or decreases for the period ended July 31, 2023.

 

- 31 -

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end NPORT-EX 3 efh_thealgerinstitutional.htm SOI